The Prevention of Cerebrovascular and Cardiovascular Events of Ischemic Origin with Terutroban in Patients with a History of Ischemic Stroke or Transient Ischemic Attack (PERFORM) Study: Baseline Characteristics of the Population

By  

Cerebrovascular Diseases, Vol. 27, Iss. 6, 2009-04 ,pp. : 608-613

Karger

Access to resources Recommend Favorite

Rationale and Design of a Randomized, Double-Blind, Parallel-Group Study of Terutroban 30 mg/day versus Aspirin 100 mg/day in Stroke Patients: The Prevention of Cerebrovascular and Cardiovascular Events of Ischemic Origin with Terutroban in Patients with a History of Ischemic Stroke or Transient Ischemic Attack (PERFORM) Study

By  

Cerebrovascular Diseases, Vol. 27, Iss. 5, 2009-04 ,pp. : 509-518

Karger

Access to resources Recommend Favorite

Risk of Recurrent Cerebrovascular Events in Patients with Cryptogenic Stroke or Transient Ischemic Attack and Patent Foramen Ovale: The FORI (Foramen Ovale Registro Italiano) Study

By  

Cerebrovascular Diseases, Vol. 31, Iss. 2, 2010-11 ,pp. : 109-116

Karger

Access to resources Recommend Favorite

Incidence and Predictors of Ischemic Stroke Events during Hospitalization in Patients with Transient Ischemic Attack

By  

Cerebrovascular Diseases, Vol. 37, Iss. 5, 2014-06 ,pp. : 330-335

Karger

Access to resources Recommend Favorite

Cerebral Microbleeds and Cognitive Function in Ischemic Stroke or Transient Ischemic Attack Patients

By  

Dementia and Geriatric Cognitive Disorders, Vol. 40, Iss. 3-4, 2015-06 ,pp. : 130-136

Karger

Access to resources Recommend Favorite